Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes-Reference-Cited by-同舟云学术

Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes

Published:2012-08 Issue:2 Volume:97 Page:258-266
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Horowitz Michael,Flint Anne,Jones Karen L.,Hindsberger Charlotte,Rasmussen Mads F.,Kapitza Christoph,Doran Selena,Jax Thomas,Zdravkovic Milan,Chapman Ian M.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference47 articles.

1. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans;Flint;J Clin Invest,1998

2. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2;Gutzwiller;Am J Physiol,1999

3. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study;Zander;Lancet,2002

4. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity;Flint;Int J Obes,2001

5. Glucagon-like peptide-1 infusion must be maintained for 24h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment;Larsen;Diabetes Care,2001

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance;International Journal of Molecular Sciences;2024-08-08

2. Semaglutide and obesity: beyond the nutritional and lifestyle intervention?;Minerva Endocrinology;2024-07

3. Do anti-obesity medical treatments have a direct effect on adipose tissue?;Annales d'Endocrinologie;2024-06

4. A pharmacokinetic study comparing the biosimilar HEC14028 and Dulaglutide (Trulicity®) in healthy Chinese subjects;Clinical and Translational Science;2024-04

5. Current Status of Therapeutic Peptides for the Management of Diabetes Mellitus;International Journal of Peptide Research and Therapeutics;2024-02-20